<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01095237</url>
  </required_header>
  <id_info>
    <org_study_id>mdt-09k006</org_study_id>
    <nct_id>NCT01095237</nct_id>
  </id_info>
  <brief_title>Clinical Pilot-Study of ProEndoTecc Vascular Grafts as Superficial Femoral Artery Bypass / Interponate</brief_title>
  <official_title>Multicenter, Clinical Pilot-Study of ProEndoTecc Vascular Grafts (6, 7 or 8 mm Diameter) as Superficial Femoral Artery Bypass/Interponate</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NonWoTecc Medical GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>MDT Medical Device Testing GmbH</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>NonWoTecc Medical GmbH</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-center, clinical pilot-study of ProEndoTecc Vascular Grafts (6, 7 or 8 mm&#xD;
      Diameter) as superficial femoral artery bypass/interponate.&#xD;
&#xD;
      The aim of this study is to demonstrate safety of implantation, patency and durability of a&#xD;
      new type of vascular graft.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Study has been halted due to safety reasons&#xD;
  </why_stopped>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">November 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary patency of device</measure>
    <time_frame>6, 12, 24 months after implatation</time_frame>
    <description>Primary Patency of treated arterial segment at 6 month after intervention. Primary Patency is defined by objective demonstration via colour-coded Doppler sonography or angiography that the entire length of the graft remain patent with no further intervention required for symptomatic recurrent disease.&#xD;
In case this information is not available, primary patency might be declared, if any the following criteria are fulfilled: Present ABI increased of ≥0.1 compared to preoperative status Present PAD-Grade according to Rutherford increased by one degree Palpable pulse distal of prosthesis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Guarding Safety variables</measure>
    <time_frame>6,12, 24 months after implantation</time_frame>
    <description>Peri-interventional monitoring resp. haemorrhages, haematomas&#xD;
Aneurysm in the grafted segment&#xD;
Fistula to the grafted segment&#xD;
Fibrosis at and around implantation site&#xD;
Death</description>
  </secondary_outcome>
  <enrollment type="Actual">33</enrollment>
  <condition>Peripheral Arterial Disease</condition>
  <condition>Peripheral Vascular Disease</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ProEndoTecc Vascular Graft</intervention_name>
    <description>Implantation of the device as an interponate / bypass of the superficial femoral artery</description>
    <other_name>ProEndoTecc Vascular Graft Prosthesis</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female or male patient from 18 to 89 years of age&#xD;
&#xD;
          -  Superficial femoral artery occlusion from 5 to 40 cm in length (above the knee joint),&#xD;
&#xD;
          -  Patient must present with intermittent claudication, with resistance to medical&#xD;
             therapy and exercise or critical ischemia,&#xD;
&#xD;
          -  Patient has Rutherford grade 3, 4, or 5 occlusive vascular disease,&#xD;
&#xD;
          -  Women of childbearing age must have negative pregnancy test prior to inclusion&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Bleeding diathesis&#xD;
&#xD;
          -  Patient has known coagulation disorders including hypercoagulability&#xD;
&#xD;
          -  Presence of one or several previously placed endo-prosthesis or grafts in the diseased&#xD;
             extremity (below iliacs)&#xD;
&#xD;
          -  Other than 6-8 mm diameter graft is needed.&#xD;
&#xD;
          -  Patients PAD state is in Fontaine Grade IV, Rutherford Grade 6 (Patient has active&#xD;
             infection or pronounced necrosis in the region of graft placement)&#xD;
&#xD;
          -  Patient has an acute embolic arterial occlusion&#xD;
&#xD;
          -  Life-expectancy less than 6 month due to co-morbidity or other situation that would&#xD;
             make the patient an unlikely candidate for follow-up visits&#xD;
&#xD;
          -  Patient had percutaneous transluminal angioplasty at the implant site within the&#xD;
             previous 30 days&#xD;
&#xD;
          -  Participation in another clinical study less than 30 days prior to inclusion&#xD;
&#xD;
          -  Patient is in need of, or is scheduled for, a cardiac surgical procedure or a&#xD;
             different vascular surgical procedure&#xD;
&#xD;
          -  Pregnant or breast feeding female patients&#xD;
&#xD;
          -  Multiple graft (implant) needed&#xD;
&#xD;
          -  Patients unable to understand the full meaning of the informed consent&#xD;
&#xD;
          -  Subjects who, in the opinion of the investigator, will be inappropriate for inclusion&#xD;
             into this trial or will not comply with requirements of the study&#xD;
&#xD;
          -  Subjects who are imprisoned (according to MPG §20.3)&#xD;
&#xD;
          -  Patients who are lawfully kept in an institution&#xD;
&#xD;
          -  Participation in this trial at an earlier stage&#xD;
&#xD;
          -  Current participation in another clinical trial&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Staedtisches Klinikum Karlsruhe gGmbH</name>
      <address>
        <city>Karlsruhe</city>
        <state>Baden-Wuerttemberg</state>
        <zip>76133</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Deggendorf, Dpt. of Vascular- and Endovascular Surgery</name>
      <address>
        <city>Deggendorf</city>
        <state>Bavaria</state>
        <zip>94469</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Muenchen-Pasing</name>
      <address>
        <city>Muenchen</city>
        <state>Bavaria</state>
        <zip>81241</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Nuernberg Sued Dpt. of Vascular Surgery</name>
      <address>
        <city>Nuernberg</city>
        <state>Bavaria</state>
        <zip>90471</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Krankenhaus Barmherzige Brüder, Dpt. of Vascular Surgery</name>
      <address>
        <city>Regensburg</city>
        <state>Bavaria</state>
        <zip>93049</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinik fuer Gefaesschirurgie St-Bonifatius-Hospital Lingen</name>
      <address>
        <city>Lingen</city>
        <state>Lower Saxony</state>
        <zip>49808</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Luisenhospital Dpt. of Vascular Surgery</name>
      <address>
        <city>Aachen</city>
        <state>Nordrhein-Westfalen</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Knappschaftskrankenhaus Bottrop Dpt. of Vascular Surgery</name>
      <address>
        <city>Bottrop</city>
        <state>Nordrhein-Westfalen</state>
        <zip>46242</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Clinic and Polyclinic for Vascular Surgery</name>
      <address>
        <city>Cologne</city>
        <state>Nordrhein-Westfalen</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Evangelisches Krankenhaus Dpt. of Vascular Surgery</name>
      <address>
        <city>Muelheim</city>
        <state>Nordrhein-Westfalen</state>
        <zip>45468</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sana Clinic Remscheid Dpt. of Vascular Surgery</name>
      <address>
        <city>Remscheid</city>
        <state>Nordrhein-Westfalen</state>
        <zip>42859</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Gefaesschirurgische Klinik St-Marienhospital Bonn</name>
      <address>
        <city>Bonn</city>
        <state>North Rhine-Westphalia</state>
        <zip>53115</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <study_first_submitted>March 23, 2010</study_first_submitted>
  <study_first_submitted_qc>March 29, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2010</study_first_posted>
  <last_update_submitted>July 8, 2014</last_update_submitted>
  <last_update_submitted_qc>July 8, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Peripheral Arterial Disease</keyword>
  <keyword>Peripheral Vascular Disease</keyword>
  <keyword>PAD</keyword>
  <keyword>vascular prosthesis</keyword>
  <keyword>revascularization</keyword>
  <keyword>patency</keyword>
  <keyword>blood vessel</keyword>
  <keyword>Rutherford</keyword>
  <keyword>ABI</keyword>
  <keyword>Ankle Brachial Index</keyword>
  <keyword>Vascular Graft</keyword>
  <keyword>Carbothane</keyword>
  <keyword>ProEndoTecc</keyword>
  <keyword>implantation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vascular Diseases</mesh_term>
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

